Bristol-Myers Squibb (BMY) net assets (shareholders' equity)

Net assets · fiscal 2025
$18.47B

Bristol-Myers Squibb (BMY) had net assets of $18.47B at the end of fiscal 2025 (December 31, 2025). That is 13.1% higher than the $16.34B of fiscal 2024. Figures as of 18 Nov 2026, 19:48 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$18.47B
Change on fiscal 2024
+13.1%
Growth, 5 years
−13.4% a year
Growth, 10 years
+2.6% a year
Highest on record
$51.60Bfiscal 2019
Lowest on record
$11.74Bfiscal 2017
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Bristol-Myers Squibb net assets (shareholders' equity), in more detail

Over the five fiscal years to 2025 net assets shrank at a compound 13.4% a year; over ten years the rate was 2.6% a year. Across the 18 fiscal years on record (2008–2025), the highest was $51.60B in fiscal 2019 and the lowest $11.74B in fiscal 2017.

History · 18 fiscal years

Net assets by fiscal year

Bristol-Myers Squibb net assets (shareholders' equity), year by year

Bristol-Myers Squibb (BMY) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$18.47B 13.1% up
2024$16.34B 44.5% down
2023$29.43B 5.3% down
2022$31.06B 13.6% down
2021$35.95B 5.0% down
2020$37.82B 26.7% down
2019$51.60B 267.7% up
2018$14.03B 19.5% up
2017$11.74B 27.4% down
2016$16.18B 13.4% up
2015$14.27B 3.9% down
2014$14.85B 2.0% down
2013$15.15B 11.2% up
2012$13.62B 14.6% down
2011$15.96B 1.5% up
2010$15.71B 5.9% up
2009$14.84B 21.3% up
2008$12.24B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Bristol-Myers Squibb and comparable companies
CompanyNet assetsFiscal year
Medtronic MDT$49.46B2026
Bristol-Myers Squibb BMY$18.47B2025
Sanofi SNY€71.38B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BMY

Bristol-Myers Squibb, figure by figure

Bristol-Myers Squibb (BMY) overview: price, valuation and scorecardAll health care companies by market value

Bristol-Myers Squibb net assets (shareholders' equity): questions and answers

What are Bristol-Myers Squibb's net assets?

Bristol-Myers Squibb (BMY) had net assets of $18.47B at the end of fiscal 2025 (December 31, 2025). That is 13.1% higher than the $16.34B of fiscal 2024.

What is the growth rate of Bristol-Myers Squibb's net assets?

Over the five fiscal years to 2025 net assets shrank at a compound 13.4% a year; over ten years the rate was 2.6% a year.

What are the highest and lowest net assets figures on record for Bristol-Myers Squibb?

Across the 18 fiscal years on record (2008–2025), the highest was $51.60B in fiscal 2019 and the lowest $11.74B in fiscal 2017.

How is Bristol-Myers Squibb's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Bristol-Myers Squibb it is on record here for 18 fiscal years, 2008 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bristol-Myers Squibb (BMY) net assets (shareholders' equity)”, data as of 18 November 2026. https://funkfolio.com/stock/BMY/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.